Search
Assertio Holdings Inc
ASRTAdd to Watchlist
23.495USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
151.86MMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
ROLVEDON
68.22M
57.47%
INDOCIN products
18.91M
15.92%
Sympazan
11.35M
9.56%
other
10.67M
8.99%
SPRIX Nasal Spray
7.95M
6.70%
Other
1.61M
1.36%
By RegionUSD
Name
Revenue
Proportion
United States
118.71M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
ROLVEDON
68.22M
57.47%
INDOCIN products
18.91M
15.92%
Sympazan
11.35M
9.56%
other
10.67M
8.99%
SPRIX Nasal Spray
7.95M
6.70%
Other
1.61M
1.36%